This site is intended for US health care
professional only.
Health Resources
Digital Health Award Winner for Clinician Web-based Health Portal
In 2018, about 4.5 million people in the US had Chronic Liver Disease1
Chronic Liver Disease can lead toCirrhosis2
Up to 80% of patients with Cirrhosis will eventually develop some form of Hepatic Encephalopathy (HE)*3
*Ranging from minimal to overt.
After a diagnosis of HE, patients had a 1 yearsurvival rate of 48%*4
*Based on data from 49,000 Medicare enrollees with cirrhosis and continuous Part D (prescription) coverage from 2008-2014.
In 2018, 37% of hospitalized patients with overt hepatic encephalopathy (OHE) were readmitted within 30 days*5
*HE cases are identified by ICD-10 codes K70.41 (alcoholic hepatic failure with coma), K71.11 (toxic liver disease with hepatic necrosis, with coma), K72.01 (acute and subacute hepatic failure with coma), K72.11 (chronic hepatic failure with coma), K72.90 (hepatic failure, unspecified without coma), and K72.91 (hepatic failure, unspecified with coma). Unless otherwise specified, hospital case data include primary and secondary diagnoses. Hospital case data for 2018 were collected from October 1, 2017, to September 30, 2018.
Here’s how you can Impact Care for patients with Chronic Liver Disease
Vilstrup H, Amodio P, Bajaj J, et al. Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver. Hepatology. 2014;60(2):715-735.
Tapper EB, Aberasturi D, Zhao Z, et al. Outcomes after hepatic encephalopathy in population-based cohorts of patients with cirrhosis. Aliment Pharmacol Ther. 2020;51(12):1397-1405.
Data on file. Forte 2020. Salix Pharmaceuticals, Bridgewater, NJ.
LIVERHEALTHNOW | Specialists Are Committed to Guideline-driven Quality Care
The website you are about to visit is not affiliated with Salix Pharmaceuticals or its affiliated entities and is not responsible for the content, format, maintenance, or policies of the website you are about to visit. Salix Pharmaceuticals or its affiliated entities do not monitor non-affiliated websites for accuracy. This link does not imply endorsement or support of any program, products, or services associated with the website.